Cabinet Plasseraud Opposition, Tisagenlecleucel, (Ep3214091)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Médecins du Monde opposition, Tisagenlecleucel, (EP3214091 )
Countries: Europe (EPO) Date: 2019
-
Miltenyi Biotec GmbH opposition, Tisagenlecleucel, (EP3214091)
Countries: Europe (EPO) Date: 2019
-
Public Eye opposition, Tisagenlecleucel, (EP3214091)
Countries: Europe (EPO) Date: 2019
-
Médecins du Monde opposition, Sofosbuvir, (EP2604620)
Countries: Europe (EPO) Date: 2017
-
European Public Health Alliance (EPHA) opposition, Sofosbuvir, (EP2604620)
Countries: Europe (EPO) Date: 2017
-
LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Page White & Farrer opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
ter Meer Steinmeister & Partner opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Médecins Sans Frontières (MSF) opposition, Sofosbuvir, (EP2604620)
Countries: Europe (EPO) Date: 2017
-
Médecins du Monde opposition, Sofosbuvir, (EP2203462)
Countries: Europe (EPO) Date: 2015